Drug Type TIL therapy |
Synonyms NUMARZU-001 |
Target |
Mechanism PD-1 modulators(Programmed cell death protein 1 modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Phase 2 | ES | 25 Jul 2022 | |
Advanced Triple-Negative Breast Carcinoma | Phase 2 | ES | - | 20 Jul 2022 |
Metastatic Triple-Negative Breast Carcinoma | Phase 2 | ES | - | 20 Jul 2022 |
Phase 1/2 | Metastatic Triple-Negative Breast Carcinoma Third line | Last line ER Negative | HER2 Negative | PR Negative | 3 | NUMARZU-001 | jtpzblyank(agbnbicaeb) = most were related to blood system disorders secondary to chemotherapy (including anemia, neutropenia, and lymphocyte count decrease). jfbceaugxm (pajlchlxcn ) View more | Positive | 16 May 2024 |